SCHEMBL13624583

SCHEMBL13624583

CC(=O)c1oc2cccnc2c1N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.40
RAB9A P51151 4/20 0.40
KDM4E B2RXH2 3/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
LIMK1 P53667 1/20 0.39
LMNA P02545 1/20 0.38
ALDH1A1 P00352 2/20 0.37
NPC1 O15118 4/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
AHR P35869 1/20 0.36
TP53 P04637 1/20 0.36
ATM Q13315 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
PARP1 P09874 1/20 0.36
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2220909 0.85 LIMK1 (0.46) BRD4RAB9AKDM4EL3MBTL1HPGD
SCHEMBL2950634 0.83 KDM4E (0.60) RAB9AKDM4EL3MBTL1HPGDTSHR
SCHEMBL19587047 0.73 LMNA (0.46) RAB9AKDM4EL3MBTL1TSHRHSD17B10
SCHEMBL21283315 0.73 KDM4E (0.34) RAB9AKDM4EL3MBTL1HPGDTSHR
SCHEMBL30168106 0.73 KDM4E (0.68) RAB9AKDM4EHPGDTSHRALDH1A1
SCHEMBL6857835 0.73 KDM4E (0.68) RAB9AKDM4EHPGDTSHRALDH1A1
SCHEMBL4140971 0.72 EDNRA (0.49) BRD4RAB9AKDM4EL3MBTL1HPGD
SCHEMBL2946788 0.71 SMN1; SMN2 (0.58) BRD4RAB9AKDM4EL3MBTL1HPGD
SCHEMBL13925859 0.71 KDM4E (0.40) BRD4RAB9AKDM4EL3MBTL1HPGD
SCHEMBL9693742 0.70 TSHR (0.45) BRD4RAB9AKDM4EL3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622582-B2 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one TIBOTEC BVBA (BE) 2009-11-24 US disclosed
US-7622582-B2 Derivatives of 1-phenyl-benzofuro[3,2]pyridin-2(1H)-one TIBOTEC BVBA (BE) 2009-11-24 US disclosed
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES TIBOTEC BVBA (BE) 2007-09-13 US disclosed
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES TIBOTEC BVBA (BE) 2007-09-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213320-A1 4-SUBSTITUTED-1,5-DIHYDRO-PYRIDO[3,2-B]INDOL-2-ONES NR2C2, CYP4B1, OXER1 BRD4 710/4885RAB9A 3809/4885KDM4E 3819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.